Resilience to Sleep Deprivation and Changes in Sleep Architecture in Shoonya Meditators
Launched by BETH ISRAEL DEACONESS MEDICAL CENTER · Aug 24, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a short 15-minute meditation practice can affect sleep patterns and brain function, especially after a night of good sleep versus a night without enough sleep. Researchers want to see if meditation can help improve how well people think and feel after being sleep-deprived. The study is currently looking for participants, and anyone aged 18 and older who either practices Shoonya meditation or takes regular naps can apply.
To take part, you must be healthy and able to travel to Boston, and you should not have any history of serious neurological or psychiatric conditions, certain medication use, or significant substance abuse. If you join the trial, you can expect to participate in meditation sessions and cognitive tests to see how your sleep and thinking skills are affected. This study could provide valuable insights into the benefits of meditation for sleep and mental performance.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Shoonya meditation program participants/individuals eligible to participate who are healthy adults of age 18 or older, and reside in the United States. Participants must be able and willing to travel to Boston.
- • 2. Nap Group: Healthy adults of age 18 or older that reside in the United States, nap regularly (at least 3 times a week), and do not meditate regularly.
- Exclusion Criteria:
- • 1. History of any neurological condition (i.e. Parkinson's disease, Alzheimer's disease, Huntington's disease, brain tumors, brain surgery, or multiple sclerosis)
- • 2. History of any psychiatric disorder, within last 5 years (i.e. anxiety, psychosis, posttraumatic stress disorder, attention deficit hyperactive disorder)
- • 3. Current use of cognition enhancing medications
- • 4. Active history (within the last 5 years) of alcohol or drug abuse (\> 10 drinks per week)
- • 5. History (within the last 5 years) of stroke/aneurysm
- • 6. Recent history (\< 3 months) of seizures
- • 7. 60 years of age or older
- • 8. History of Heart Attack and Ejection Fraction less than or equal to 30%
- • 9. Pregnancy
- • 10. Non-English speaking
- • 11. History/Diagnosis of any sleep disorder
- • 12. Consumption of 3 or more cups of coffee a day
- • 13. Previously learned shoonya meditation (for the meditator groups)
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center (BIDMC) is a leading academic medical center located in Boston, Massachusetts, affiliated with Harvard Medical School. Renowned for its commitment to cutting-edge research and innovation in healthcare, BIDMC fosters a collaborative environment that integrates patient care, education, and scientific investigation. The center actively sponsors clinical trials across a variety of disciplines, aiming to advance medical knowledge and improve patient outcomes. With a focus on translational medicine, BIDMC's research initiatives engage multidisciplinary teams to address complex health challenges and translate findings into effective therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Balachundhar Subramaniam, MD, MPH
Principal Investigator
Beth Israel Deaconess Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials